Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 407 shares trading hands.
Analyst Upgrades and Downgrades
Separately, StockNews.com initiated coverage on shares of Calithera Biosciences in a research note on Saturday. They issued a “hold” rating for the company.
Read Our Latest Stock Analysis on Calithera Biosciences
Calithera Biosciences Price Performance
About Calithera Biosciences
Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.
Further Reading
- Five stocks we like better than Calithera Biosciences
- Short Selling: How to Short a Stock
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What is Insider Trading? What You Can Learn from Insider Trading
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Do ETFs Pay Dividends? What You Need to Know
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
